|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 31/573 | (2006.01) |
| (11) | Number of the document | 2814469 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13709499.1 |
| Date of filing the European patent application | 2013-02-12 | |
| (97) | Date of publication of the European application | 2014-12-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation | 2020-05-25 |
| (86) | Number | PCT/GB2013/050311 |
| Date | 2013-02-12 |
| (87) | Number | WO 2013/121184 |
| Date | 2013-08-22 |
| (30) | Number | Date | Country code |
| 201202433 | 2012-02-13 | GB | |
| 201261599704 P | 2012-02-16 | US | |
| 201261600958 P | 2012-02-20 | US |
| (72) |
HUATAN, Hiep, GB
ROSS, Richard, GB
WHITAKER, Martin, GB
|
| (73) |
Neurocrine UK Limited,
Cardiff Medicentre Heath Park, Cardiff, Glamorgan CF14 4UJ,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Hidrokortizono kontroliuojamo atpalaidavimo kompozicija |
| HYDROCORTISONE CONTROLLED RELEASE FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2026-01-20 | 14 | 289.00 EUR |
| 2027-02-12 |